Vapotherm (NYSE:VAPO – Get Rating) is set to post its quarterly earnings results after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter. Vapotherm has set its FY 2022 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call […]
A number of firms have modified their ratings and price targets on shares of Vapotherm (NYSE: VAPO) recently: 4/23/2022 – Vapotherm was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the […]
Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]
Vapotherm (NYSE:VAPO – Get Rating) and USA Equities (OTCMKTS:USAQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Profitability This table compares Vapotherm and USA Equities’ net margins, […]
Vapotherm (NYSE:VAPO – Get Rating) had its target price reduced by research analysts at Canaccord Genuity Group from $21.00 to $12.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 82.37% from the […]